Research and Markets, the largest resource for market research information in world providing essential market research reports, industry research, industry analysis, forecasts, market studies, company profiles and country reports.
Welcome - Home - Register - Login - Help/FAQ - 0 items View Basket
Worlds Largest Market Research Resource - 722239 Live Reports
Search Research and Markets
  Search
Enter keywords, a title or
a report id number below.





Advanced   
Company search
Register for free email updates of market research
Currency
  Select a currency for use throughout the site



Viewing report

Order by Fax
Printer Friendly
PDF Brochure
Send to Friend
Enquire before Buying
| More
Hard CopyAdd to Basket
ElectronicAdd to Basket



Niche Cancers 2001: Acute Myeloid Leukemia
Datamonitor, July 2001


  Description  
  Table of Contents  
    
    
    
   
 Enquire before Buying  
 Send to a Friend  

Disease Overview - incidence, classification and diagnosis * Market Analysis - global sales and profiles of individual drugs currently on the market * Unmet Needs - unmet needs associated with current drug therapies, the characteristics needed to offer superior treatment and the projected direction of future R&D activity * Pipeline * Analysis - R&D pipeline, with profiles of the key drugs in development * Market * Forecasts - future trends in the incidence of each cancer type and drug sales forecasts to 2007



Customers who bought this item also bought

Drugs of Tomorrow 2001: Stable Angina - An Unsatisfactory R&D Pipeline Facing Chronic Unmet Needs

Pipeline Insight: Acute Stroke: Commercial Risk Offsets High Unmet Need

Pipeline and Commercial Insight: Hepatitis C - High Unmet Need Drives Rapid Innovation

Pipeline Insight: HIV - Novel NNRTIs address crucial unmet need

Allergy Drug Pipeline and R&D 2009

Allergy Drug Pipeline and R&D 2009

Biomarkers: The Future of Next-Generation Drug R&D

Cancer Therapeutics - Market Insight and R&D Pipeline Analysis

Drugs in the Pipeline--An R&D Analysis

Pipeline Insight: Depression - Novel Drugs to Grow Third-line Market

Pipeline Insight: Neuropathic Pain - Emerging Drugs Fail to Capitalize in Lucrative Market

Stakeholder Opinions: Small Cell Lung Cancer and Malignant Mesothelioma - Limited R&D Activity Provides Opportunity for Early-Phase Pipeline Drugs



Top of page


   All rights reserved. � Copyright 2009 Research and Markets
   Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster


Research and Markets RSS Feeds